Propranolol as therapy for cerebral cavernous malformations: a cautionary note

J Transl Med. 2022 Apr 5;20(1):160. doi: 10.1186/s12967-022-03360-4.

Affiliations

¹ Department of Neurological Surgery, University of Chicago Medicine and Biological Sciences, 5841 S. Maryland, MC 3026, Chicago, IL, 60637, USA.
² Department of Molecular Genetics and Microbiology, Duke University, Durham, NC, USA.
³ Department of Neurosurgery, Barrow Neurological Institute, Phoenix, AZ, USA.
⁴ Department of Neurological Surgery, University of Chicago Medicine and Biological Sciences, 5841 S. Maryland, MC 3026, Chicago, IL, 60637, USA. iawad@uchicago.edu.

^# Contributed equally.

No abstract available

Publication types

Letter
Research Support, N.I.H., Extramural

MeSH terms

Brain Neoplasms*
Hemangioma, Cavernous, Central Nervous System* / drug therapy
Humans
Magnetic Resonance Imaging
Propranolol / therapeutic use

Substances

Propranolol

Grants and funding